We are live on ! Find out more
VTRS icon

Viatris

472 hedge funds and large institutions have $12.8B invested in Viatris in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 195 increasing their positions, 167 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 195 | Existing positions reduced: 167

2.88% more ownership

Funds ownership: 72.96%75.84% (+2.9%)

12% less funds holding

Funds holding: 537472 (-65)

16% less capital invested

Capital invested by funds: $15.2B → $12.8B (-$2.42B)

35% less funds holding in top 10

Funds holding in top 10: 2013 (-7)

41% less call options, than puts

Call options by funds: $131M | Put options by funds: $222M

66% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 90

Holders
472
Holders Change
-65
Holders Change %
-12.1%
% of All Funds
11.77%
Holding in Top 10
13
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-35%
% of All Funds
0.32%
New
31
Increased
195
Reduced
167
Closed
90
Calls
$131M
Puts
$222M
Net Calls
-$90.9M
Net Calls Change
+$14.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.38B -$116M -3,429,906 -7%
BlackRock
2
BlackRock
New York
$1.29B +$17.5M +516,361 +1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.11B +$83.3M +2,452,708 +7%
Pzena Investment Management
4
Pzena Investment Management
New York
$713M +$352M +10,381,697 +84%
State Street
5
State Street
Massachusetts
$699M +$60.1M +1,769,308 +9%
Invesco
6
Invesco
Georgia
$498M +$84.7M +2,496,069 +19%
PC
7
Paulson & Co
New York
$462M -$41.2M -1,215,000 -8%
GC
8
Greenlight Capital
New York
$337M +$1.45M +42,600 +0.4%
Goldman Sachs
9
Goldman Sachs
New York
$304M +$74.1M +2,181,494 +29%
FPA
10
First Pacific Advisors
California
$297M +$43.5M +1,281,740 +16%
Franklin Resources
11
Franklin Resources
California
$269M +$805K +23,700 +0.3%
MIFH
12
Migdal Insurance & Financial Holdings
Israel
$198M -$20.6M -606,483 -9%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$192M +$37.7M +1,111,522 +22%
Northern Trust
14
Northern Trust
Illinois
$180M +$24.2M +712,600 +14%
AQR Capital Management
15
AQR Capital Management
Connecticut
$179M +$173M +5,084,005 +937%
Fidelity International
16
Fidelity International
Bermuda
$151M -$7.31M -215,448 -4%
TCIM
17
TIAA CREF Investment Management
New York
$147M -$6.93M -204,043 -4%
Norges Bank
18
Norges Bank
Norway
$137M -$8.7M -256,266 -6%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$128M +$7.9M +232,762 +6%
Deutsche Bank
20
Deutsche Bank
Germany
$118M +$9.04M +266,184 +8%
MMH
21
Menora Mivtachim Holdings
Israel
$115M -$2.38M -70,000 -2%
TA
22
Teachers Advisors
New York
$114M +$10.3M +302,620 +9%
O
23
OrbiMed
New York
$113M +$21.1M +621,900 +21%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$111M +$20.8M +612,513 +21%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$111M -$234M -6,885,977 -66%

VTRS Hedge Fund Activity: Q3 2017 in Review

472 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q3 2017, worth a combined $12.8B — down 16% from $15.2B a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of VTRS and 31 opened new positions — a net loss of 59 holders — while 167 trimmed existing stakes and 195 added.

The largest buyer was Pzena Investment Management, adding an estimated $352M. The largest seller was T. Rowe Price Associates, cutting an estimated $234M.

  • 472 institutional investors held Viatris (VTRS) as of Q3 2017, down from 537 in Q2 2017.
  • Funds reported $12.8B of Viatris stock for Q3 2017, down 16% quarter-over-quarter.
  • 31 funds opened new Viatris positions in Q3 2017 and 90 closed out, a net change of -59 holders.
  • The largest Viatris buyer in Q3 2017 was Pzena Investment Management, an estimated $352M added.
  • The largest Viatris seller in Q3 2017 was T. Rowe Price Associates, an estimated $234M sold.

Based on aggregated 13F filings for Q3 2017.